Loading...
Cell Therapy Wind Down And Cash Reserves Will Drive A Leaner, Stronger Biotech Future
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
7.7%7D
1.3%1Y
7.7%7D
1.3%You can edit this narrative until Dec 10 12:11 AM. Then, changes will post as Updates.